Results 21 to 30 of about 19,123,678 (263)

Activity of Javanese Ginger, Turmeric, Garlic, and Pomegranate Flower on LDL-C and Total-C on Dyslipidemia Model Rats

Global Medical & Health Communication, 2021
High levels of LDL cholesterol are risk factors for coronary heart disease. Different types of medicinal plants have hypolipidemic effects. The study aimed to compare the potential of Javanese ginger ethanol extract, turmeric, garlic, and pomegranate ...
Larissa Larissa, Penny Setyawati Martioso, Diana Krisanti Jasaputra   +2 more
doaj   +1 more source

The effect of LDL-C on T-cell metabolism and its implications for cerebrovascular function

, 2023
Martens, Christopher R.INTRODUCTION: Alzheimer’s disease (AD) mortality is the fifth leading cause of death in adults 65 years and older. Aging is the greatest risk factor for AD, and is associated with an increase in chronic, sterile, low-grade ...
DeConne, Theodore M.
core   +1 more source

Serum level of monocyte chemotactic protein 1, N-terminal brain natural peptide in patients with coronary heart disease after nutritional changes [PDF]

Journal of Medical Biochemistry
Background: Coronary heart disease (CHD) is a leading cause of morbidity among elderly populations, with inflammation and cardiac dysfunction indicated by elevated MCP-1 and NT-proBNP levels.
Ding Yueyou, Ji Wenhui, Zheng Hongchao, Wang Zhancheng   +3 more
doaj   +1 more source

LDL-C goal achievement rates among patients with dyslipidemia (based on the 2015 Korean guidelines).

, 2020
LDL-C, low-density lipoprotein cholesterol.
Siin Kim (3949709), Yi Qian (466487), Pratik P. Rane (8378820), Sola Han (6532826), Hae Sun Suh (7249091), Zhongyun Zhao (5326046)   +5 more
core   +1 more source

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importnace of Lp(a) [PDF]

, 2012
We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n = 1,156), the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT; n = 895), and the ...
Postmus, Iris, Colhoun, H.M., McKeigue, Paul M, Stanton, A.V., Trompet, S., Hyde, Craig, Colhoun, Helen M, Caulfield, M., Shields, Denis C., Hitman, Graham A, CARDS, Poulter, Neil, Shields, D.C., Sever, P., Chatterjee, Aurobindo, Trompet, Stella, Durrington, Paul N, Deshmukh, H.A., DeMicco, D.A., Calle, Roberto A., Hitman, Graham A., Neil, A., McKeigue, Paul M., Fuller, John H., Postmus, I., Hitman, G.A., DeMicco, David A., Johnson, T., ?, ?, Calle, Roberto A, Betteridge, D.J., Livingstone, Shona, Ford, Ian, McKeigue, P.M., Stanton, Alice V., Jukema, J.W., Johnson, Toby, Durrington, Paul N., Neil, Andrew, PROSPER Investigators, Livingstone, S., Jukema, J. Wouter, ASCOT, Colhoun, Helen, Ford, I., Sever, Peter, Fuller, J.H., Jukema, J Wouter, Caulfield, Mark, Fuller, John H, Chatterjee, A., Deshmukh, Harshal A, Calle, R.A., Hyde, C., Charlton-Menys, V., Poulter, N., Charlton-Menys, Valentine, DeMicco, David A, Betteridge, D John, McKeigue, Paul M.; id_orcid, Betteridge, D. John, Durrington, P.N., Colhoun, Helen M., Shields, Denis C, Deshmukh, Harshal A., Stanton, Alice V   +65 more
core   +1 more source

Effect of Carrageenans on Vegetable Jelly in Humans with Hypercholesterolemia

Marine Drugs, 2019
Changes in lipid profile constitute the main risk factor for cardiovascular diseases. Algae extracted carrageenans are long-chain polysaccharides and their ability to form gels provides for the formation of vegetable jelly.
Ana Valado, Maria Pereira, Armando Caseiro, João P. Figueiredo, Helena Loureiro, Carla Almeida, João Cotas, Leonel Pereira   +7 more
doaj   +1 more source

LDL-C goal achievement rates based on the 2015 Korean guidelines and LDL-C distributions categorized by the use of lipid-modifying treatment.

, 2020
LDL-C, low-density lipoprotein cholesterol; LMT, lipid-modifying treatment.
Siin Kim (3949709), Yi Qian (466487), Pratik P. Rane (8378820), Sola Han (6532826), Hae Sun Suh (7249091), Zhongyun Zhao (5326046)   +5 more
core   +1 more source

Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia:Results of a 24week, double-blind, randomized Phase 3 trial [PDF]

, 2014
Background:Efficacy and safety of alirocumab were compared with ezetimibe in hypercholesterolemic patients at moderate cardiovascular risk not receiving statins or other lipid-lowering therapy. Methods In a Phase 3, randomized, double-blind, double-dummy
Merlet, Laurence, Robinson, Jennifer G., Kastelein, John J.P., Roth, Eli M., Colhoun, Helen M., Pordy, Robert, Taskinen, Marja-Riitta, Ginsberg, Henry N., Kastelein, John J. P., Baccara-Dinet, Marie T.   +9 more
core   +1 more source

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations

Biomedicines, 2022
New more effective lipid-lowering therapies have made it important to accurately determine Low-density lipoprotein-cholesterol (LDL-C) at both high and low levels. LDL-C was measured by the β-quantification reference method (BQ) (N = 40,346) and compared
Maureen Sampson, Anna Wolska, Justine Cole, Rafael Zubirán, James D. Otvos, Jeff W. Meeusen, Leslie J. Donato, Allan S. Jaffe, Alan T. Remaley   +8 more
doaj   +1 more source

Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis

Open Medicine, 2021
Gestational diabetes mellitus (GDM) can have adverse effects on pregnancy. GDM is associated with changes in the lipid profile of pregnant women. Finding out the early ways to diagnose GDM can prevent the adverse outcomes.
Rahnemaei Fatemeh Alsadat, Pakzad Reza, Amirian Azam, Pakzad Iraj, Abdi Fatemeh   +4 more
doaj   +1 more source